Long QT Syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) Created page with "__NOTOC__ {{Long QT Syndrome}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures for the..." |
Farima Kahe (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Effective measures for the secondary prevention of long QT syndrome [[Implantable cardioverter-defibrillators|implantable cardioverter-defibrillator]], [[magnesium sulfate]] and [[beta blockers]] for high risk patients. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Effective measures for the secondary prevention of long QT syndrome include:<ref name="pmid11233951">{{cite journal |vauthors=Passman R, Kadish A |title=Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes |journal=Med. Clin. North Am. |volume=85 |issue=2 |pages=321–41 |date=March 2001 |pmid=11233951 |doi=10.1016/s0025-7125(05)70318-7 |url=}}</ref><ref name="pmid20301308">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Alders M, Bikker H, Christiaans I |title= |journal= |volume= |issue= |pages= |date= |pmid=20301308 |doi= |url=}}</ref><ref name="pmid12628082">{{cite journal |vauthors=Engelstein ED |title=Long QT syndrome: a preventable cause of sudden death in women |journal=Curr Womens Health Rep |volume=3 |issue=2 |pages=126–34 |date=April 2003 |pmid=12628082 |doi= |url=}}</ref> | |||
*[[Implantable cardioverter-defibrillators|Implantable cardioverter-defibrillator]] (ICD) in high-risk patients | |||
*[[Magnesium sulfate]] for recurrence of long QT-related ventricular ectopic beats or [[Torsades de pointes]] | |||
*[[Beta blockers]] for patients with congenital LQTS and a history of syncope, seizures, or resuscitated [[sudden cardiac death]] | |||
*[ | |||
*[ | |||
*[ | |||
==References== | ==References== | ||
Latest revision as of 16:48, 16 April 2020
|
Long QT Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Long QT Syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Long QT Syndrome secondary prevention |
|
Risk calculators and risk factors for Long QT Syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief:
Overview
Effective measures for the secondary prevention of long QT syndrome implantable cardioverter-defibrillator, magnesium sulfate and beta blockers for high risk patients.
Secondary Prevention
Effective measures for the secondary prevention of long QT syndrome include:[1][2][3]
- Implantable cardioverter-defibrillator (ICD) in high-risk patients
- Magnesium sulfate for recurrence of long QT-related ventricular ectopic beats or Torsades de pointes
- Beta blockers for patients with congenital LQTS and a history of syncope, seizures, or resuscitated sudden cardiac death
References
- ↑ Passman R, Kadish A (March 2001). "Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes". Med. Clin. North Am. 85 (2): 321–41. doi:10.1016/s0025-7125(05)70318-7. PMID 11233951.
- ↑ Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Alders M, Bikker H, Christiaans I. PMID 20301308. Vancouver style error: initials (help); Missing or empty
|title=(help) - ↑ Engelstein ED (April 2003). "Long QT syndrome: a preventable cause of sudden death in women". Curr Womens Health Rep. 3 (2): 126–34. PMID 12628082.